HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Piyanuch Sripayap Selected Research

romidepsin (FK228)

1/2014Romidepsin overcomes cell adhesion-mediated drug resistance in multiple myeloma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Piyanuch Sripayap Research Topics

Disease

2Leukemia
04/2014 - 12/2011
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2014 - 12/2011
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2014
1Multiple Myeloma
01/2014
1Myeloid Leukemia (Leukemia, Myelocytic)
12/2011
1Neoplasms (Cancer)
12/2011
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2011

Drug/Important Bio-Agent (IBA)

1Azacitidine (5 Azacytidine)FDA Link
04/2014
1romidepsin (FK228)FDA Link
01/2014
1Etoposide (VP 16)FDA LinkGeneric
12/2011
1Daunorubicin (Cerubidine)FDA LinkGeneric
12/2011
1Aurora KinasesIBA
12/2011
1Cytarabine (Cytosar-U)FDA LinkGeneric
12/2011
1Phosphotransferases (Kinase)IBA
12/2011
1Vincristine (Oncovin)FDA LinkGeneric
12/2011
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
12/2011
1tozasertibIBA
12/2011
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2011

Therapy/Procedure

1Therapeutics
12/2011